Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT

Bone Marrow Transplantation, 05/25/2012

Increased likelihood of receiving day +11 MTX suggests that Folinic acid (FA) ameliorates MTX toxicity, such as severe mucositis. FA administration for MTX GVHD prophylaxis should be studied in a prospective, randomized fashion.

Print Article Summary Cat 2 CME Report